Home › Trial NCT03335267
Investigator Initiated Trial of CPX-351 for Untreated Acute Myeloid Leukemia
- Trial IDNCT03335267
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorWeill Medical College of Cornell University
- Enrollment30
- Start date2017-10-19
- ConditionsLeukemia, Myeloid, Acute
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.